SCHEMBL30401622

SCHEMBL30401622

Oc1cnnc2c(Br)csc12

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25169268 1.00 GPR35 (0.31) GPR35
SCHEMBL25172583 0.78 PDPK1 (0.36)
SCHEMBL25168095 0.78
SCHEMBL25167692 0.76 GPR35 (0.31) GPR35
SCHEMBL30433615 0.76 GPR35 (0.31) GPR35
SCHEMBL25467561 0.74 PDE4B (0.32)
SCHEMBL4166956 0.68 KDM4E (0.38) GPR35
SCHEMBL22866890 0.67 HPGD (0.37) GPR35
SCHEMBL31373103 0.67 PDPK1 (0.36) GPR35
SCHEMBL31337031 0.63 MAPK1 (0.33) GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4426702-A1 CONDENSED-PYRAZINE AMINE DERIVATIVES FOR TREATING SCA3 Skyhawk Therapeutics, Inc. (US) 2024-09-11 EP disclosed
EP-4426704-A1 CONDENSED PYRIDAZINE AMINE DERIVATIVES TREATING SCA3 Skyhawk Therapeutics, Inc. (US) 2024-09-11 EP disclosed
WO-2023081857-A1 CONDENSED PYRIDAZINE AMINE DERIVATIVES TREATING SCA3 SKYHAWK THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed
WO-2023081858-A1 CONDENSED-PYRAZINE AMINE DERIVATIVES FOR TREATING SCA3 SKYHAWK THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed